Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Z.ZhangY
Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual glucose-dependent insulinotropicGLP-1RAs, have evolved from metabolic therapies to agents with either proven or potential protective effects on the kidney and heart
Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus
Plasma total GIP levels significantly increased from baseline with the oil gavage in WT mice, independent of housing temperature, and cold-stressed male GLPDRKO mice (Fig
US$ 27.79
US$ 20.60
US$ 27.31
US$ 22.89
US$ 27.27
